A narrative review of the pharmacology of ginsenoside compound K
Authors:
Open Access
- 1 February 2022
- journal article
- review article
- Published by AME Publishing Company in Annals of Translational Medicine
- Vol. 10 (4) , 234
Abstract
Background and Objective: The ginsenoside compound K [20-o-beta-dglucopyranosyl-20 (S)-protopanaxadiol; CK] is the main deglycosylated metabolite of ginsenoside. As a rare ginsenoside converted from the active substance of ginseng by intestinal bacteria, CK has higher biological activity than other ginsenosides. It has demonstrated diverse and intriguing biological activities, including anti-carcinogenic, anti-diabetic, anti-inflammation, anti-allergy, anti-angiogenesis, anti-aging, neuroprotective, and hepatoprotective effects. The purpose of this review was to elucidate the rich pharmacological activities and related mechanisms of ginsenoside CK in vivo and in vitro, as well as the potential therapeutic value of CK as a drug in a variety of systemically related diseases. Methods: The PubMed database was searched for articles published in English from February 2008 to December 2021 using related keywords such as “Ginsenoside compound K”, “compound K”, and “CK”. About 140 research papers and reports written in English were identified. These papers mainly concentrated on the pharmacological activities of CK in cancer prevention, immune regulation, diabetic improvement, central nervous system (CNS) protection, cardiovascular protection, skin improvement, and hepatoprotection. Key Content and Findings: This paper describes the synthesis, pharmacokinetics, and adverse reactions of CK, as well as great detailed summarized of the relevant pharmacological activities. Such diverse intriguing biological properties of CK have been found. Conclusions: On account of CK’s numerous pharmacological activities and anti-carcinogenic, anti-inflammation, antiallergic, anti-diabetic, anti-angiogenesis, anti-aging, neuroprotective, and hepatoprotective effects, strong evidence is available for CK as a preventive or therapeutic agent for various diseases. However, further studies are needed to evaluate the safety and effectiveness of CK as a drug and its application in the medical field.Keywords
This publication has 102 references indexed in Scilit:
- Pharmacokinetics of ginsenoside Rb1 and its metabolite compound K after oral administration of Korean Red Ginseng extractJournal of Ginseng Research, 2013
- A ginseng metabolite, compound K, induces autophagy and apoptosis via generation of reactive oxygen species and activation of JNK in human colon cancer cellsCell Death & Disease, 2013
- Compound K, a Ginsenoside Metabolite, Inhibits Colon Cancer Growth via Multiple Pathways Including p53-p21 InteractionsInternational Journal of Molecular Sciences, 2013
- Anti-cancer effects of ginsenoside compound k on pediatric acute myeloid leukemia cellsCancer Cell International, 2013
- Inhibitory Effects of Ginsenoside Metabolites, Compound K and Protopanaxatriol, on GABACReceptor-Mediated Ion CurrentsThe Korean Journal of Physiology & Pharmacology, 2013
- Ginsenoside compound K, not Rb1, possesses potential chemopreventive activities in human colorectal cancerInternational Journal of Oncology, 2012
- Biotransformation of Ginsenoside Rb1to Prosapogenins, Gypenoside XVII, Ginsenoside Rd, Ginsenoside F2, and Compound K by Leuconostoc mesenteroides DC102Journal of Ginseng Research, 2011
- Ginsenoside Rb1 and its metabolite compound K inhibit IRAK-1 activation—The key step of inflammationBiochemical Pharmacology, 2011
- Compound K, a Metabolite of Ginseng Saponin, Induces Mitochondria-Dependent and Caspase-Dependent Apoptosis via the Generation of Reactive Oxygen Species in Human Colon Cancer CellsInternational Journal of Molecular Sciences, 2010
- Compound K, a metabolite of ginseng saponin, induces apoptosis via caspase-8-dependent pathway in HL-60 human leukemia cellsBMC Cancer, 2009